Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
This entry refers to a novel long noncoding RNA transcript that is antisense to the PDCD2 (Programmed cell death protein 2) gene, annotated as ENSG00000267024 in Ensembl and LOC124904695 in some NCBI/RefSeq records. It is mapped as an antisense RNA overlapping the PDCD2 gene locus, potentially regulating PDCD2 expression via transcriptional interference, a phenomenon described for similar conserved antisense transcripts in mouse, chicken, and human[2]. However, there is no published experimental evidence attributing a confirmed biological function, disease association, or relevance as a therapeutic target, biomarker, or drug-interacting molecule[5][2]. Entries like this in genomic datasets often remain poorly characterized ("novel transcript" status), with some considered possible artifacts or incomplete annotation, as suggested by transcriptome studies[2]. Its principal relevance is as a genomic feature that may participate in regulatory mechanisms, not as a target for drug discovery or clinical intervention.
None established; antisense transcripts may interfere with sense transcription through transcriptional interference or RNA-based mechanisms, but specific drugs/mechanisms do not exist for this target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, antisense to PDCD2.